SCHEMBL24809088

SCHEMBL24809088

CC(=O)Nc1ccc(S(=O)(=O)C(C)(C)C)c(C)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.71
LMNA P02545 1/20 0.51
MAPT P10636 2/20 0.51
TP53 P04637 1/20 0.51
CDK1 P06493 1/20 0.50
PKM P14618 3/20 0.49
TDP1 Q9NUW8 1/20 0.46
IDH1 O75874 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ENPP2 Q13822 1/20 0.44
ABCC9 O60706 1/20 0.44
ABCC8 Q09428 1/20 0.44
KCNJ11 Q14654 1/20 0.44
KCNJ8 Q15842 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPK1 P28482 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
MAOA P21397 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2318661 0.83 ALDH1A1 (1.00) ALDH1A1LMNAMAPTTP53CDK1
SCHEMBL14502114 0.83 ALDH1A1 (0.76) ALDH1A1LMNAMAPTTP53CDK1
SCHEMBL539699 0.82 ALDH1A1 (0.73) ALDH1A1LMNAMAPTTP53CDK1
SCHEMBL6192129 0.82 ALDH1A1 (0.73) ALDH1A1LMNAMAPTTP53CDK1
Hydrochloric Acid SCHEMBL7531560 0.82 ALDH1A1 (0.73) ALDH1A1LMNAMAPTTP53CDK1
SCHEMBL2314592 0.79 ALDH1A1 (0.69) ALDH1A1LMNAMAPTTP53CDK1
SCHEMBL20364520 0.79 ALDH1A1 (0.69) ALDH1A1LMNAMAPTTP53CDK1
SCHEMBL13900915 0.76 CA1 (0.62) ALDH1A1MAPTPKMTDP1SMN1; SMN2
SCHEMBL24218721 0.76 ALDH1A1 (0.64) ALDH1A1LMNAMAPTTP53CDK1
SCHEMBL2336203 0.75 POLB (0.68) ALDH1A1LMNAMAPTPKMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411426-A1 SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411426-A1 SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF IDE, SI, GPR119 ALDH1A1 1111/4885LMNA 2054/4885MAPT 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.